SHARE-BASED COMPENSATION (SARS Activity) (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)	12 Months Ended
	Jan. 29, 2022	Jan. 30, 2021
Number of Underlying Shares Outstanding [Roll Forward]
Number of Underlying Shares, Outstanding (in shares)	236,139	384,757
Number of Underlying Shares, Granted (in shares)	0
Number of Underlying Shares, Exercised (in shares)	(111,868)
Number of Underlying Shares, Forfeited or expired (in shares)	(36,750)
Weighted-Average Exercise Price [Roll Forward]
Weighted-Average Exercise Price, Outstanding (in dollars per share)	$ 32.55	$ 33.04
Weighted-Average Grant Date Fair Value, Granted (in dollars per share)	0
Weighted-Average Exercise Price, Exercised (in dollars per share)	26.95
Weighted-Average Exercise Price, Forfeited or exercised (in dollars per share)	$ 54.73
Aggregate Intrinsic Value, Outstanding	$ 1,276,809
Weighted-Average Remaining Contractual Life, Outstanding	2 years 3 months 18 days
Number of Underlying Shares, Stock appreciation rights exercisable (in shares)	236,139
Weighted-Average Exercise Price, Stock appreciation rights exercisable (in dollars per share)	$ 32.55
Aggregate Intrinsic Value, Stock appreciation rights exercisable	$ 1,276,809
Weighted- Average Remaining Contractual Life, Stock appreciation rights exercisable	2 years 3 months 18 days